STUDY AIM: Study of clinical, diagnostic and therapeutic aspects of mesenteric and mesocolic @entity3609 . MATERIAL AND METHODS: 15 cases were retrospectively analysed: 5 adults (mean age 36.8 years, range 26 to 46) and 10 @entity1 (mean age 23 months, range 0 to 5 years). Diagnosis was prenatal in 1 case. Symptoms were: abdominal @entity158 (80%), @entity221 (20%), abdominal mass (46%), @entity432 (33%), chylous @entity8056 1 case. @entity5 were mesenteric (86%) or mesocolic (13%). RESULTS: Complete resection was performed in 11 cases (including 10 bowel resections), incomplete resections in 3 and doxycycline sclerotherapy once. Mean follow-up is 5 years. One recurrence occurred 6 years after complete resection and 1 @entity5 increased after incomplete resection. @entity1 treated by sclerotherapy was non symptomatic with a 3.5 years follow-up after last injection. CONCLUSION: Mesenteric and mesocolic @entity3609 are @entity5 . Complete resection should be performed whenever possible. Intracystic sclerotherapy with @entity47931 is possible for unresectable @entity2696 .

[IMesenteric and mesocolic XXXX . Diagnostic and therapeutic management].

@entity1 :: ('9606', 'Species') :: ['children', 'Patient'] @entity3609 :: ('MESH:D018191', 'Disease') :: ['cystic lymphangiomas'] @entity47931 :: ('CHEBI:50845', 'Chemical') :: ['doxycyclin'] @entity5 :: ('MESH:D009369', 'Disease') :: ['Tumours', 'congenital benign tumours', 'tumour'] @entity8056 :: ('MESH:C536897', 'Disease') :: ['ascitis'] @entity2696 :: ('MESH:D008202', 'Disease') :: ['lymphangiomas'] @entity158 :: ('MESH:D010146', 'Disease') :: ['pain'] @entity432 :: ('MESH:D001157', 'Disease') :: ['occlusive syndrome'] @entity221 :: ('MESH:D005334', 'Disease') :: ['fever']
@entity3609 :: (MESH:D018191,Disease) :: ['cystic lymphangiomas']
